Maravai LifeSciences Holdings, Inc. Class A Common Stock

MRVINASDAQ • USD
7.40 USD
↘ 0.14 (1.86%)AT CLOSE (03:59 PM EST)
7.42
↗ 0.01 (0.20%)
POST MARKET (AS OF 07:30 PM EST)
Post Market
AS OF 07:30 PM EST
7.42
↗ 0.01 (0.20%)
🔴Market: CLOSED

Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) is currently trading at $7.41. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, MRVI trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 16, 2026.

Open?$7.30
High?$7.60
Low?$7.09
Prev. Close?$7.54
Volume?1.5M
Avg. Volume?2.4M
VWAP?$7.40
Rel. Volume?0.63x
Bid / Ask
Bid?$7.40 × 10.3K
Ask?$7.57 × 100
Spread?$0.17
Midpoint?$7.49
Valuation & Ratios
Market Cap?1.1B
Shares Out?149.3M
Float?124.6M
Float %?83.7%
P/E Ratio?N/A
P/B Ratio?5.64
EPS?-$0.44
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
Employees
410
Market Cap
1.1B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-11-20
Address
10770 WATERIDGE CIRCLE SUITE 200
SAN DIEGO, CA 92121
Phone: (858) 546-0004
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
56
Momentum?
8
Short Sent.?
29
Piotroski F-Score?4/9Mixed
Altman Z-Score?2.57Grey
Confidence?63%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?11.28%High
Short Interest?14.1M
Days to Cover?6.8
Free Float124.6M
Avg Daily Volume2.1M
Settlement Date2026-10-30
Financial Health
Current Ratio?4.66Strong
Quick Ratio?3.35Strong
Cash Ratio?2.21Strong
Debt/Equity?0.90Moderate
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
75/100
P/E?
N/A▾
P/B?
Peers
100
S&P
33
5.64FAIR▾
P/S?
Peers
100
S&P
28
5.19FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-176.9CHEAP▾
EV/Sales?
Peers
100
S&P
30
5.67FAIR▾
Returns & Efficiency
ROE?
S&P
5
-33.5%WEAK▾
ROA?
S&P
3
-10.9%WEAK▾
Cash Flow & Enterprise
FCF?$-12540000
Enterprise Value?$1.2B
Fundamentals ratios updated end of day